Search for: "Holman, Appeal of"
Results 161 - 180
of 213
Sorted by Relevance
|
Sort by Date
17 Nov 2015, 1:51 pm
Court of Appeals granted a stay that will allow the NSA’s bulk telephony metadata collection program to continue through November 29th. [read post]
1 Aug 2015, 2:36 pm
In December last year Holman J refused an adoption order in a case where the father had only been identified after the making of the placement order and placement of the child. [read post]
28 Feb 2012, 2:38 am
The webinar will be presented by Professor Christopher Holman and attorney Robert H. [read post]
10 May 2015, 5:48 pm
We reverse the court of appeals and render judgment for Molina. [read post]
28 Mar 2010, 7:46 pm
However, on appeal, the Federal Circuit reversed and held the patent invalid under 35 USC 112, first paragraph, for failing to provide an adequate written description. [read post]
13 Mar 2009, 2:00 am
(GenericsWeb) India’s Human Genome Bill (Spicy IP) Indian drugmakers push into US generics market (GenericsWeb) Uganda: Indian generic manufacturers concerned anti-counterfeit legislation may threaten market in Uganda and surrounding territories (Afro-IP) UK: Court of Appeal admonishes counsel for dilatory actions involved in parallel British and EPO proceedings: Eli Lilly & Co v Human Genome Sciences (Hal Wegner) (PatLit) US: President Obama to lift stem cell limits on… [read post]
28 Jul 2014, 8:12 am
Price pleaded guilty to making a false statement when applying for a bank loan; he withdrew his guilty plea and on appeal, a jury found him not guilty. [read post]
21 Oct 2009, 6:13 am
– response to IAM article suggesting pharmaceutical companies will subsidise Rio 2016 (IP tango) EU: India, Brazil to file WTO complaint against the EU over ‘seizures’ of pharma drug consignments (Spicy IP) US: PhRMA supports follow-on biologics regulatory pathway providing 12 years of data exclusivity (Patent Docs) US: Senators Orrin Hatch, Barbara Mikulski, Michael Enzi and Kay Hagan write in support of 12-year data exclusivity period (Patent Docs) US: New England… [read post]
21 Oct 2009, 5:13 am
- response to IAM article suggesting pharmaceutical companies will subsidise Rio 2016 (IP tango) EU: India, Brazil to file WTO complaint against the EU over 'seizures' of pharma drug consignments (Spicy IP) US: PhRMA supports follow-on biologics regulatory pathway providing 12 years of data exclusivity (Patent Docs) US: Senators Orrin Hatch, Barbara Mikulski, Michael Enzi and Kay Hagan write in support of 12-year data exclusivity period (Patent Docs) US: New England Journal of Medicine say… [read post]
7 Oct 2010, 5:27 pm
On appeal, the court amended the judgment to order the production of the metadata. [read post]
29 Dec 2010, 2:57 am
Mayo Collaborative Services (Patently-O) (Filewrapper) (Patents4Life) (Patent Docs) (Inventive Step) US: Lawsuit alleging infringement of canine genotyping patent raise interesting patent eligibility issues (Holman’s Biotech IP Blog) US: Will Bessie, Porky, Puss and Poly get their meds? [read post]
21 Oct 2009, 5:13 am
- response to IAM article suggesting pharmaceutical companies will subsidise Rio 2016 (IP tango) EU: India, Brazil to file WTO complaint against the EU over 'seizures' of pharma drug consignments (Spicy IP) US: PhRMA supports follow-on biologics regulatory pathway providing 12 years of data exclusivity (Patent Docs) US: Senators Orrin Hatch, Barbara Mikulski, Michael Enzi and Kay Hagan write in support of 12-year data exclusivity period (Patent Docs) US: New England Journal of Medicine say… [read post]
20 Jul 2011, 4:04 am
422/10 Georgetown University, University of Rochester and Loyola University of Chicago v Comptroller-General of Patents, Designs and Trade Marks (SPC blog) EU: EPO – Danisco v Novozymes continued – Oppositions Division, District Court of The Hague arrive at opposite conclusions – both decisions to be appealed (EPLAW) EU: Transiting through legal uncertainty? [read post]
17 Nov 2010, 1:48 am
(Patently-O) US: Amicus brief filed by Alnylam Pharmaceuticals argues that Funk Bros. is about obviousness, not patent eligibility: AMP v USPTO (Holman’s Biotech IP Blog) US: Amicus briefs in AMP v USPTO: Genetic Alliance (Patent Docs) US: Patent expirations will stabilise the pharmaceutical industry (BiotechBlog) US: Generic industry headed for a ‘180-day exclusivity cliff’ (FDA Law Blog) US: PTO clarifies PTE availability in post-PhotoCure and post-Ortho-McNeil world;… [read post]
16 Mar 2011, 3:50 am
Actavis (Kluwer Patent Blog) Valsartan – Norway: Valsartan case goes on appeal: Novartis v Actavis (The SPC Blog) Xeloda (Capecitabine) – US: Hoffmann-La Roche files patent infringement complaint against Accord following Para IV challenge (Patent Docs) [read post]
19 Sep 2010, 5:36 pm
Next Week in the Courts On 21 September 2010 Thorpe and Smith LJJ will hear a renewed oral hearing for permission to appeal [read post]
5 Feb 2012, 5:01 pm
The webinar will be presented by Professor Christopher Holman and attorney Robert H. [read post]
4 Nov 2022, 4:00 am
Court of Appeals for the District of Columbia Circuit declined to review earlier rulings that found lawmakers are entitled to the documents in the legal battle. [read post]
18 Oct 2010, 3:07 am
SEB S.A (Patently-O) (Inventive Step) (Filewrapper) New false marking bill introduced in the House (Patent Docs) (271 Patent Blog) (FDA Law Blog) UK: Court of Appeal gives guidance on enablement: Novartis AG & Cibavision AG v. [read post]
8 Feb 2008, 7:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included:Record labels sue Baidu over providing links to file-sharing sites: (Ars Technica), (Techdirt), (Out-Law), (IP Law360), (Copyfight), Merck’s Fosamax patent expires: Watson Pharmaceuticals to distribute authorized generic version, Teva and Barr also launch FDA approved generic versions: (SmartBrief), (Patent Circle), (In … [read post]
